-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
▎Edited by WuXi AppTec Content Team
Cerevance announced today that it has entered into a multi-year strategic research and development cooperation with Merck & Co.Alzheimer's disease is the most common neurodegenerative disease in the elderly.
▲Introduction to the NETSseq technology platform (Image source: Cerevance's official website)
[1] Cerevance Establishes Strategic Research Collaboration with Merck for the Discovery of Novel Targets in Alzheimer's Disease.
Disclaimer: The WuXi AppTec content team focuses on introducing global biomedical health research progress